University scientists in Hong Kong get rare US approval for clinical trials of new Chinese medicine-based constipation treatment

Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.

Baptist University’s CDD-2101 first botanical drug authorised for clinical trials in United States, which could lead to international market.